StockData
Panacea Life Sciences Holdings, Inc. logo

Panacea Life Sciences Holdings, Inc. (PLSH) stock

PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)

Close on Oct 19, 2026Market cap $1.15MP/E –Yield –

Panacea Life Sciences profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Panacea Life Sciences's profit margin for the twelve months ending Mar 31, 2024 was -277.5%. For fiscal 2023 it was -336.1%, against -561.9% the year before. The highest annual figure on record is -58.0% in fiscal 2020.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2023Dec 31, 2023-336.1%+225.9
FY2022Dec 31, 2022-561.9%−329.7
FY2021Dec 31, 2021-232.2%−174.2
FY2020Dec 31, 2020-58.0%+2840.3
FY2019Dec 31, 2019-2898.3%+165166.0
FY2015Dec 31, 2015-168064.3%−133255.5
FY2014Dec 31, 2014-34808.8%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2024Mar 31, 2024-136.9%+127.5
Q4 FY2023Dec 31, 2023-230.0%+294.9
Q3 FY2023Sep 30, 2023-618.4%+117.2
Q2 FY2023Jun 30, 2023-467.1%−49.2
Q1 FY2023Mar 31, 2023-264.4%+332.0
Q4 FY2022Dec 31, 2022-524.8%−201.2
Q3 FY2022Sep 30, 2022-735.5%−210.1
Q2 FY2022Jun 30, 2022-417.9%−426.6
Q1 FY2022Mar 31, 2022-596.4%−668.8
Q4 FY2021Dec 31, 2021-323.6%−311.3
Q3 FY2021Sep 30, 2021-525.4%−244.1
Q2 FY2021Jun 30, 20218.7%−2.0
Q1 FY2021Mar 31, 202172.4%+409.9
Q4 FY2020Dec 31, 2020-12.3%+4204.1
Q3 FY2020Sep 30, 2020-281.3%+3086.4
Q2 FY2020Jun 30, 202010.6%+3378.3
Q1 FY2020Mar 31, 2020-337.6%+8485.1
Q4 FY2019Dec 31, 2019-4216.4%+9098.1
Q3 FY2019Sep 30, 2019-3367.7%+109518.2
Q2 FY2019Jun 30, 2019-3367.7%+31792.4
Q1 FY2019Mar 31, 2019-8822.7%−5223.6
Q4 FY2015Dec 31, 2015-13314.6%–
Q4 FY2014Dec 31, 2014-112885.9%–
Q3 FY2014Sep 30, 2014-35160.1%–
Q2 FY2014Jun 30, 2014-3599.1%–

More Panacea Life Sciences figures

See a number that looks wrong?